RxDoctor Payments Data

Courtney Granadero

Nurse Practitioner · Winston Salem, NCNPI 1154996221

Payments from drug & device makers

$5,031in general payments, 2019–2025

Across 206 payments — averaging $24.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$890
  • GSK$618
  • AstraZeneca$595
  • Regeneron Healthcare Solutions, Inc.$579
  • United Therapeutics Corporation$552
  • Mallinckrodt Hospital Products Inc.$336
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$4,93798%
  • Education$952%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,031 in reported general payments places this provider in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter296$225,315
OfevNintedanib Esylate13$152,081
Breztri AerosphereBudesonide/Glycopyr/Formoterol111$79,192
Spiriva RespimatTiotropium Bromide70$48,913
Stiolto RespimatTiotropium Br/Olodaterol Hcl71$39,891
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr72$36,709
Breo ElliptaFluticasone/Vilanterol66$29,260
Combivent RespimatIpratropium/Albuterol Sulfate41$20,083
SymbicortBudesonide/Formoterol Fumarate47$18,111
Advair HfaFluticasone Propion/Salmeterol33$12,864
Incruse ElliptaUmeclidinium Bromide23$8,910
Fluticasone-SalmeterolFluticasone Propion/Salmeterol52$8,363
Wixela InhubFluticasone Propion/Salmeterol53$7,081
Albuterol Sulfate HfaAlbuterol Sulfate196$5,382
Bevespi AerosphereGlycopyrrolate/Formoterol Fum14$5,171

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta$618$300,193457 claims
Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat, Combivent Respimat$890$260,967195 claims
AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere$595$102,474172 claims
MerckDulera$155$3,79611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →